Wave Life Sciences names Monika Vnuk as chief business officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer
September 22, 2026 7:30 AM EDTDr. Vnuk brings substantial business and corporate development leadership experience from Sanofi, Blackstone, and Pfizer
CAMBRIDGE, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of Monika Vnuk, MD, as Chief Business Officer. Dr. Vnuk will join Waves executive team and lead business development, corporate development, and alliance management.
We are thrilled to welcome Dr. Vnuk to Wave in a newly created leadership role as... More



